Correction: Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics (Oncogene, (2022), 41, 19, (2764-2777), 10.1038/s41388-022-02288-9)

Tadashi Iida, Yasuyuki Mizutani, Nobutoshi Esaki, Suzanne M. Ponik, Brian M. Burkel, Liang Weng, Keiko Kuwata, Atsushi Masamune, Seiichiro Ishihara, Hisashi Haga, Kunio Kataoka, Shinji Mii, Yukihiro Shiraki, Takuya Ishikawa, Eizaburo Ohno, Hiroki Kawashima, Yoshiki Hirooka, Mitsuhiro Fujishiro, Masahide Takahashi, Atsushi Enomoto

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

Affiliation 11 was assigned by mistake to Masahide Takahashi instead of Mitsuhiro Fujishiro The correct affiliation are Mitsuhiro Fujishiro2,11 Masahide Takahashi102Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. 10International Center for Cell and Gene Therapy, Fujita Health University, Toyoake, Japan. 11Present address: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. The original article has been corrected.

Original languageEnglish
Pages (from-to)3302
Number of pages1
JournalOncogene
Volume41
Issue number23
DOIs
Publication statusPublished - 03-06-2022

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics (Oncogene, (2022), 41, 19, (2764-2777), 10.1038/s41388-022-02288-9)'. Together they form a unique fingerprint.

Cite this